Early D-Dimer Screening for Pulmonary Vein Stump Thrombosis After Lung Lobectomy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41871767.
- Also identified by DOI 10.1016/j.athoracsur.2026.03.027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To address the risk of cerebral infarction from pulmonary vein stump thrombosis (PVST) after lung lobectomy, this study evaluated D-dimer measurement as an early screening tool, given that routine contrast-enhanced computed tomography is impractical. We retrospectively reviewed 198 patients who underwent lung lobectomy and postoperative contrast-enhanced computed tomography between January 2021 and August 2024. D-dimer levels were measured on postoperative day 1. Receiver operating characteristic curve analysis evaluated D-dimer's discriminative ability, and multivariable logistic regression identified independent risk factors for PVST, which were diagnosed on postoperative days 5 to 7 by computed tomography. PVST was detected in 38 of 198 patients (19.2%), typically associated with left upper lobectomy and long pulmonary vein stumps. Postoperative day 1 D-dimer levels were significantly higher in the thrombosis-positive group (median, 1.8 vs 1.3 μg/mL; P < .001) but did not correlate with thrombus volume. Receiver operating characteristic analysis yielded an area under the curve of 0.692; a negative cutoff of 1.2 μg/mL provided a negative predictive value of 96.9%. Multivariable analysis identified 3 independent predictors for thrombosis: interstitial pneumonia, left upper lobectomy, and postoperative day 1 D-dimer level ≥1.2 μg/mL. Overall postoperative complication rates and postoperative hospital duration were similar, although several complications were more frequent in the thrombosis-positive group. Cerebral infarction occurred in 4 patients (1.6%). D-dimer measurement on postoperative day 1 shows promise for preliminary PVST screening. However, our single-center retrospective findings require prospective multicenter validation before the 1.2 μg/mL cutoff is implemented in routine practice.
Medical subject headings
- Fibrin Fibrinogen Degradation Products
- Pneumonectomy
- Postoperative Complications
- Venous Thrombosis
- Pulmonary Veins